Renal Effects of Erythropoietin in Humans

NCT01584921 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Renal Effects

Interventions

DRUG: Erythropoietin (Epoetin-beta, NeoRecormon®)
DRUG: Erythropoietin (Epoetin-beta, NeoRecormon®)
DRUG: Placebo

Sponsor

University of Copenhagen

Collaborators

[object Object]